Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kaplan

Showing results (831-840 of 861) with videos related to

Pageof 87
Sort By:
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Advances in Radiation Oncology|September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control SeriesJesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
International Journal of Radiation Oncology, Biology, Physics|September 4, 2025
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the KidneyMuhammad Ali, Rohann J M Correa, David Pryor, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
HGG Advances|March 5, 2021
Germline mutation in <i>POLR2A</i>: a heterogeneous, multi-systemic developmental disorder characterized by transcriptional dysregulationAdam W Hansen, Payal Arora, Michael M Khayat, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Cell Reports|June 1, 2022
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapyYannan Xi, Benbo Song, Iris Ngan, et al.
Human Mutation|June 27, 2017
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disabilityRonit Marom, Mahim Jain, Lindsay C Burrage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2019
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 TrialRichard F Ambinder, Juan Wu, Brent Logan, et al.
Pageof 87

Showing results (831-840 of 861) with videos related to

Sort By:
Pageof 87
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Advances in Radiation Oncology|September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control SeriesJesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
International Journal of Radiation Oncology, Biology, Physics|September 4, 2025
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the KidneyMuhammad Ali, Rohann J M Correa, David Pryor, et al.
Bone Marrow Transplantation|September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisG N Mannis, A C Logan, A D Leavitt, et al.
HGG Advances|March 5, 2021
Germline mutation in <i>POLR2A</i>: a heterogeneous, multi-systemic developmental disorder characterized by transcriptional dysregulationAdam W Hansen, Payal Arora, Michael M Khayat, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Cell Reports|June 1, 2022
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapyYannan Xi, Benbo Song, Iris Ngan, et al.
Human Mutation|June 27, 2017
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disabilityRonit Marom, Mahim Jain, Lindsay C Burrage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2019
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 TrialRichard F Ambinder, Juan Wu, Brent Logan, et al.
Pageof 87